"India is facing a serious threat from Hepatitis C virus (HCV). It is, however, going to take a lot more than low-cost drugs to get patients cured," said Bhaumik in a press release today.
"Opportunity exists within the HIV Infrastructure in the race against HCV. A robust awareness drive, similar to the one adopted for combating HIV, should be initiated with focus on screening and early diagnosis," he said.
"Once we know where exactly the problem exists, measures to ensure affordable and effective treatment should be undertaken," the medical expert said.
"Another issue is, at present we are unaware of the magnitude of the problem. It is imperative to undertake large field studies to identify pockets and better understand HCV epidemiology," he suggested.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
